Tekbiotech-Yeast and Phage Display CRO, Expert in Nano-body and Antibody Drug Development

English

中文

English

Home
Technical Platform
Yeast Surface Display Platform
Phage Display Platform
- scFv Antibody Development Services
- Nanobody Development Services
Services
Antibody Drugability Assessment
Aptamer Discovery Service
Active Peptide Discovery Technology Service
- Targeted Peptide Library Screening Service
- Targeted Peptide Library Construction Service
Animal Immunization Technology Services
- mRNA Immune Antibody Preparation Service
- DNA Immune Antibody Preparation Service
Yeast Hybrid Technology Platform
Recombinant Antibody Expression Services
Technical Support
Nano-body Support Articles
Special topic on antibody modification
Yeast Display Technology Special Topic
Antibody Detection Service Topic
Special Topic on Phage Display Technology
CAR-T Molecule Discovery Topic
- Application And Prospects of CAR-T Technology in Tumor Immunotherapy
- CAR-T Discovery Service
Molecular Biology Service Topics
Product Center
Biosimilar Antibody Reagent
Nanobody Related Reagent
Contact Us
中文 English

Yeast Surface Display Platform

Recombinant Antibody Expression Service

Phage Display Technology Platform

Nanobody Drug Development Platform

Nanobody Research & Development Platform

Our mission:

TekBiotech specializes in delivering professional and efficient yeast display and phage display platforms, assisting you in rapidly screening and optimizing high-affinity antibodies and nano-antibodies.

Our goal:

Leverage Tek's professional platforms to accelerate your drug discovery process, advance scientific research and biotechnology breakthroughs, and contribute to global health.

Technical Platform and Capability

TekBiotech's yeast surface display technology enables rapid screening of high-affinity, fully human antibodies, powering innovative drug discovery.

Yeast Surface Display Platform

Phage Display Antibody Library: We offer libraries containing billions of naive/fully synthetic human antibodies for the screening of high-affinity ScFv/Fab fragments, accelerating early-stage antibody discovery.

Phage Display Platform

Antibody Drugability Assessment Platform: Conducts comprehensive analysis of antibody sequence and physicochemical properties to predict and optimize immunogenicity, aggregation propensity, and stability, thereby reducing clinical development risks.

Antibody Drugability Assessment Platform

TekBiotech provides comprehensive aptamer discovery services. From design and synthesis to screening high-specificity, high-affinity aptamers via SELEX technology, we deliver end-to-end solutions for diagnostics, targeted delivery, and drug development.

Aptamer Discovery Service Platform

TekBiotech provides comprehensive bio-active peptide discovery solutions, utilizing high-throughput screening to identify high-affinity targeting peptides for molecular imaging, targeted therapy, and drug delivery applications.

Active Peptide Screening Service

We deliver professional humanization and affinity optimization while maintaining parental antibody activity. Our approach significantly reduces immunogenicity to support the development of therapeutic antibodies.

Antibody Humanization & Affinity Maturation Services

Technical Topics

Common Problems and Solutions for Yeast Two-hybrid Experiments

TekBiotech has been committed to the research of yeast two-hybrid system (Y2H) for many years. TekBiotech's yeast two-hybrid system is composed of a library constructed based on the SMART method, yeas

How do you know Phage Display Peptide Library?

I. What are the different functions and uses of pIII and pVIII proteins in phage display technology?Answer:pIII and pVIII proteins play different roles in phage display technology. pIII protein is a m

Novel Peptide-Drug Conjugate (PDC) Shows Efficacy in Hepatocellular Carcinoma Models

Transarterial chemoembolization (TACE) is a standard treatment for unresectable, advanced Hepatocellular Carcinoma (HCC), the most common type of liver cancer. However, a major limitation of TACE is t

Common Problems and Solutions of Prokaryotic Expression of Recombinant Protein

TekBiotech provides one-stop services including gene cloning, vector construction and protein expression and purification to assist scientific researchers and biopharmaceutical companies.

Application And Prospects of CAR-T Technology in Tumor Immunotherapy

After years of technological accumulation, Tek Biotech has built a complete phage display technology system and yeast display system to provide customers with high-quality Car lead antibody molecule d

scFv Antibody Development Services

TekBiotech has 10 years of project development experience in providing high-quality scFv discovery services targeting targets such as proteins, peptides, small molecules, viruses, membrane proteins, a

About Tek Biotech

“Committed to providing biological research methods and services for overcoming cancer and various diseases”

Tek Biotech (Tianjin) Co., Ltd. is committed to providing customized services based on phage display and nanobody development platforms for global customers. Tek Biotech's R&D team has extensive experience in antibody discovery, recombinant antibody development, and phage library construction and screening. Our services include the production of monoclonal antibodies against humans, monkeys, rabbits, cows, sheep, alpacas, and camels using various antibody library technologies, including phage display, bacterial display, and yeast display.